vs

Side-by-side financial comparison of Ceribell, Inc. (CBLL) and PLUMAS BANCORP (PLBC). Click either name above to swap in a different company.

PLUMAS BANCORP is the larger business by last-quarter revenue ($28.6M vs $24.8M, roughly 1.2× Ceribell, Inc.). PLUMAS BANCORP produced more free cash flow last quarter ($20.3M vs $-11.0M).

Ceribell, Inc. develops and commercializes innovative portable neurodiagnostic medical devices, focused on rapid non-invasive electroencephalogram (EEG) solutions for seizure detection. Its core products serve hospital emergency departments, intensive care units, and long-term care facilities, with primary markets across North America and ongoing global expansion efforts.

Plumas Bancorp is a U.S.-based bank holding company operating through its subsidiary Plumas Bank. It provides full-spectrum retail and commercial banking services including deposit products, consumer and commercial loans, small business financing, and wealth management for individual customers, SMEs and local community groups across northern California and Nevada.

CBLL vs PLBC — Head-to-Head

Bigger by revenue
PLBC
PLBC
1.2× larger
PLBC
$28.6M
$24.8M
CBLL
More free cash flow
PLBC
PLBC
$31.2M more FCF
PLBC
$20.3M
$-11.0M
CBLL

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
CBLL
CBLL
PLBC
PLBC
Revenue
$24.8M
$28.6M
Net Profit
$-13.5M
Gross Margin
87.3%
Operating Margin
-58.9%
48.9%
Net Margin
-54.6%
Revenue YoY
35.1%
Net Profit YoY
EPS (diluted)
$-0.35
$1.56

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CBLL
CBLL
PLBC
PLBC
Q4 25
$24.8M
$28.6M
Q3 25
$22.6M
$27.4M
Q2 25
$21.2M
$20.5M
Q1 25
$20.5M
$21.8M
Q4 24
$21.2M
Q3 24
$17.2M
$21.1M
Q2 24
$20.6M
Q1 24
$19.6M
Net Profit
CBLL
CBLL
PLBC
PLBC
Q4 25
$-13.5M
Q3 25
$-13.5M
$5.1M
Q2 25
$-13.6M
$6.3M
Q1 25
$-12.8M
$7.2M
Q4 24
Q3 24
$-10.4M
$7.8M
Q2 24
$6.8M
Q1 24
$6.3M
Gross Margin
CBLL
CBLL
PLBC
PLBC
Q4 25
87.3%
Q3 25
88.3%
Q2 25
88.1%
Q1 25
87.9%
Q4 24
Q3 24
87.3%
Q2 24
Q1 24
Operating Margin
CBLL
CBLL
PLBC
PLBC
Q4 25
-58.9%
48.9%
Q3 25
-64.8%
25.2%
Q2 25
-70.5%
42.2%
Q1 25
-69.3%
46.1%
Q4 24
50.3%
Q3 24
-57.8%
50.6%
Q2 24
45.1%
Q1 24
42.8%
Net Margin
CBLL
CBLL
PLBC
PLBC
Q4 25
-54.6%
Q3 25
-59.6%
18.8%
Q2 25
-64.4%
30.8%
Q1 25
-62.4%
33.0%
Q4 24
Q3 24
-60.6%
37.1%
Q2 24
32.9%
Q1 24
31.9%
EPS (diluted)
CBLL
CBLL
PLBC
PLBC
Q4 25
$-0.35
$1.56
Q3 25
$-0.37
$0.73
Q2 25
$-0.38
$1.05
Q1 25
$-0.36
$1.20
Q4 24
$1.30
Q3 24
$-1.85
$1.31
Q2 24
$1.14
Q1 24
$1.05

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CBLL
CBLL
PLBC
PLBC
Cash + ST InvestmentsLiquidity on hand
$159.3M
$80.6M
Total DebtLower is stronger
Stockholders' EquityBook value
$155.3M
$261.1M
Total Assets
$195.8M
$2.2B
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CBLL
CBLL
PLBC
PLBC
Q4 25
$159.3M
$80.6M
Q3 25
$168.5M
$87.3M
Q2 25
$177.4M
$79.3M
Q1 25
$182.7M
$87.3M
Q4 24
$82.0M
Q3 24
$14.1M
$118.0M
Q2 24
$109.9M
Q1 24
$128.2M
Stockholders' Equity
CBLL
CBLL
PLBC
PLBC
Q4 25
$155.3M
$261.1M
Q3 25
$164.1M
$245.9M
Q2 25
$172.2M
$193.1M
Q1 25
$180.9M
$187.6M
Q4 24
$177.9M
Q3 24
$-136.0M
$181.9M
Q2 24
$165.2M
Q1 24
$161.5M
Total Assets
CBLL
CBLL
PLBC
PLBC
Q4 25
$195.8M
$2.2B
Q3 25
$199.5M
$2.2B
Q2 25
$207.7M
$1.6B
Q1 25
$213.5M
$1.6B
Q4 24
$1.6B
Q3 24
$47.1M
$1.7B
Q2 24
$1.6B
Q1 24
$1.6B

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CBLL
CBLL
PLBC
PLBC
Operating Cash FlowLast quarter
$-10.8M
$21.6M
Free Cash FlowOCF − Capex
$-11.0M
$20.3M
FCF MarginFCF / Revenue
-44.2%
70.9%
Capex IntensityCapex / Revenue
0.7%
4.6%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-41.6M
$34.4M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CBLL
CBLL
PLBC
PLBC
Q4 25
$-10.8M
$21.6M
Q3 25
$-11.1M
$5.6M
Q2 25
$-7.5M
$2.1M
Q1 25
$-11.4M
$7.5M
Q4 24
$30.5M
Q3 24
$8.0M
Q2 24
$5.1M
Q1 24
$9.2M
Free Cash Flow
CBLL
CBLL
PLBC
PLBC
Q4 25
$-11.0M
$20.3M
Q3 25
$-11.5M
$4.8M
Q2 25
$-7.6M
$2.0M
Q1 25
$-11.6M
$7.3M
Q4 24
$29.8M
Q3 24
$7.8M
Q2 24
$4.8M
Q1 24
$9.0M
FCF Margin
CBLL
CBLL
PLBC
PLBC
Q4 25
-44.2%
70.9%
Q3 25
-50.8%
17.5%
Q2 25
-35.9%
9.9%
Q1 25
-56.4%
33.7%
Q4 24
141.0%
Q3 24
37.1%
Q2 24
23.5%
Q1 24
45.8%
Capex Intensity
CBLL
CBLL
PLBC
PLBC
Q4 25
0.7%
4.6%
Q3 25
1.6%
2.9%
Q2 25
0.3%
0.2%
Q1 25
0.7%
0.8%
Q4 24
3.2%
Q3 24
0.7%
Q2 24
1.1%
Q1 24
1.0%
Cash Conversion
CBLL
CBLL
PLBC
PLBC
Q4 25
Q3 25
1.09×
Q2 25
0.33×
Q1 25
1.04×
Q4 24
Q3 24
1.02×
Q2 24
0.75×
Q1 24
1.46×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

CBLL
CBLL

Products$18.8M76%
Subscription$6.0M24%

PLBC
PLBC

Segment breakdown not available.

Related Comparisons